What is the growth forecast for the Neurovascular Coiling Assist Devices market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Neurovascular Coiling Assist Devices market?

Key drivers include rising stroke cases, technological advancements, and growing healthcare expenditure.

What challenges does the Neurovascular Coiling Assist Devices market face?

Challenges include high device costs, limited reimbursement, and stringent regulatory frameworks.

Which regions are leading the Neurovascular Coiling Assist Devices market?

North America and Europe are regional leaders, driven by advanced healthcare infrastructure.

Who are the top companies in the Neurovascular Coiling Assist Devices market?

Top companies include Medtronic, Stryker, and Terumo, offering innovative coiling assist devices.

What future opportunities exist in the Neurovascular Coiling Assist Devices market?

Future opportunities include emerging markets, increasing adoption of minimally invasive procedures.

How is technology impacting the Neurovascular Coiling Assist Devices market?

Technological advancements, such as robotics and artificial intelligence, are enhancing device efficacy.

What is the current regulatory landscape for Neurovascular Coiling Assist Devices?

The regulatory landscape is stringent, with devices requiring FDA and CE mark approvals.

What is the future outlook for the Neurovascular Coiling Assist Devices market?

The future outlook is positive, driven by growing demand, technological advancements, and increasing adoption.

Neurovascular Coiling Assist Devices - Strategic Insights: Analysis 2025 and Forecasts 2033

Neurovascular Coiling Assist Devices by Application (Neurosurgery, Internal Medicine-Neurology, Other), by Types (Coil Assist Stents, Coil Assist Balloons), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $2400 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $2400 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Neurovascular Coiling Assist Devices Market Size | CAGR 7.8 Forecast 2033

Neurovascular Coiling Assist Devices - Strategic Insights: Analysis 2025 and Forecasts 2033

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $2400 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $2400 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Neurovascular Coiling Assist Devices Market Overview

The Neurovascular Coiling Assist Devices market refers to the industry that manufactures and markets devices used to assist in neurovascular coiling procedures. As a crucial component of neurointerventional surgery, the Neurovascular Coiling Assist Devices market size is expected to experience significant growth, driven by an increasing demand for minimally invasive procedures and advancements in medical technology. The growth outlook for this market is promising, with a projected market forecast that indicates a steady expansion of the industry. Key terms such as neurovascular coiling, assist devices, and market expansion are essential in understanding the scope of this market, which encompasses various neurointerventional and medical device technologies.

Loading chart…

The current Neurovascular Coiling Assist Devices market size is approximately $1.3 billion. The market is expected to grow at a CAGR of around 8%, driven by macro drivers such as an aging population, an increasing prevalence of neurovascular diseases, and advancements in medical technology. Key forces shaping the industry include technology shifts, such as the development of more advanced coiling assist devices, regulations that govern the approval and use of these devices, and competitive intensity among market players. The largest region for Neurovascular Coiling Assist Devices is North America, while the fastest-growing region is expected to be the Asia-Pacific. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and developments in the Neurovascular Coiling Assist Devices market.

Report Overview

Report Attribute	Details
Market size value in 2025	2.40 billion
Revenue forecast in 2033	4.38 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Stryker Neurovascular; MicroVention Inc; Cerenovus; Medtronic plc; Balt Extrusion SAS; Phenox GmbH; Acandis GmbH & Co KG
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Neurovascular Coiling Assist Devices market is poised for significant growth, driven by factors such as advancements in technology and an increasing prevalence of neurovascular diseases. The market size is expected to expand, with a promising growth forecast, as manufacturers develop more sophisticated and minimally invasive coiling assist devices.

Growth Drivers2 items

Advancements in neurovascular coiling technology, including the development of more flexible and navigable coiling assist devices, are driving the Neurovascular Coiling Assist Devices market size and growth forecast.

An increasing prevalence of neurovascular diseases, such as aneurysms and arteriovenous malformations, is fueling demand for effective treatment options, including Neurovascular Coiling Assist Devices.

Restraints2 items

High costs associated with Neurovascular Coiling Assist Devices and procedures may limit market growth, particularly in regions with limited reimbursement options and stringent regulatory requirements.

The Neurovascular Coiling Assist Devices market may face challenges related to competition from alternative treatment options, such as flow diversion devices, which may impact the growth forecast and market size.

Opportunities2 items

Emerging markets, particularly in Asia-Pacific and Latin America, offer significant opportunities for growth in the Neurovascular Coiling Assist Devices market, driven by increasing demand for neurovascular treatments and a growing healthcare infrastructure.

The development of hybrid coiling assist devices, which combine multiple technologies, may provide a competitive edge for manufacturers and drive innovation in the Neurovascular Coiling Assist Devices market, ultimately influencing the market size and growth forecast.

Challenges2 items

Stringent regulatory requirements and time-consuming approval processes may hinder the introduction of new Neurovascular Coiling Assist Devices, impacting the market size and growth forecast.

The Neurovascular Coiling Assist Devices market must address supply chain complexities, including the sourcing of high-quality materials and components, to ensure consistent product quality and meet growing demand, ultimately affecting the growth forecast and market size.

Market Segmentation

Loading chart…

The Neurovascular Coiling Assist Devices market can be segmented based on Application, which includes aneurysm treatment, arteriovenous malformation (AVM) treatment, and other applications. Each application contributes significantly to the overall Neurovascular Coiling Assist Devices market size, with aneurysm treatment holding the largest share due to the high prevalence of aneurysms globally. Understanding the Neurovascular Coiling Assist Devices segmentation is crucial for market players to develop targeted strategies and capitalize on emerging opportunities.

The market can also be divided into Types, comprising detachable coils and pushable coils. Detachable coils are further sub-categorized into GDC (Guglielmi Detachable Coil) and Matrix coils, while pushable coils include Trufill and Natick coils. The detachable coils segment dominates the market due to its ease of use, high success rates, and reduced risk of complications. Analyzing the Neurovascular Coiling Assist Devices market taxonomy is essential for identifying key trends and drivers shaping the industry.

Neurovascular Coiling Assist Devices Segmentation Breakdown7 items

Application

Neurosurgery

Internal Medicine-Neurology

Other

Types

Coil Assist Stents

Coil Assist Balloons

Regional Insights

Loading chart…

The Neurovascular Coiling Assist Devices market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of neurovascular coiling assist devices, favorable policies, and significant investments in healthcare infrastructure.

In North America, key drivers include a mature ecosystem, high demographics awareness, and established infrastructure. Europe is driven by a strong ecosystem, favorable policies, and a high level of adoption. Asia Pacific's growth is fueled by increasing investments, a growing demographics, and improving infrastructure. Latin America and Middle East & Africa are expected to experience steady growth, driven by rising adoption and investments in healthcare.

The regional forecast indicates that North America will maintain its lead, while Asia Pacific will experience rapid growth. Europe will continue to be a significant contributor, driven by its mature ecosystem and high level of adoption. Latin America and Middle East & Africa will experience steady growth, driven by increasing investments and improving infrastructure.

Competitive Landscape

The Neurovascular Coiling Assist Devices market is moderately consolidated, driven by a mix of global players and local companies. The Neurovascular Coiling Assist Devices competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies emphasize regional expansion and cost advantages.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, and R&D investments. They also focus on technology, service model, channel strength, customization, and cost advantages to stay competitive. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. The following companies have distinct strategic focuses:

Stryker Neurovascular: regional expansion

MicroVention Inc: innovation pipeline

Cerenovus: premium pricing

Medtronic plc: vertical integration

Balt Extrusion SAS: local manufacturing

Phenox GmbH: OEM tie-ups

Key Neurovascular Coiling Assist Devices Companies7 items

Stryker Neurovascular

MicroVention Inc

Cerenovus

Medtronic plc

Balt Extrusion SAS

Phenox GmbH

Acandis GmbH & Co KG

Market Ecosystem

The Neurovascular Coiling Assist Devices ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, where raw materials and components are sourced; midstream, where devices are manufactured and integrated; and downstream, where products are distributed and used. Value is created and captured at each stage, with participants interacting and influencing one another to deliver neurovascular coiling assist devices to the market.

Raw material/component suppliers — provide essential materials

OEMs / manufacturers — design and produce devices

Distributors / channel partners — deliver products to healthcare facilities

Service providers / after-sales — offer maintenance and support services

End users / buyers — neurosurgeons and healthcare professionals

Regulators/standards bodies — establish and enforce industry standards

Data/analytics providers — offer insights to improve device efficacy and safety

In the Neurovascular Coiling Assist Devices ecosystem, value flows through the interactions and relationships between these participants. Control points, such as regulatory approvals and industry standards, influence the adoption of devices. Dependency risks, including input constraints and switching costs, can impact the ecosystem's efficiency. As the ecosystem differs by region, with diverse regulatory requirements and market needs, participants must navigate these complexities to succeed. A thorough value chain analysis is essential to understanding the intricacies of this ecosystem and identifying opportunities for growth and improvement.

Recent Industry Insights

The Neurovascular Coiling Assist Devices industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between Medtronic and Abbott, have focused on advancing coiling assist technologies for improved patient outcomes. Mergers and acquisitions, including the acquisition of Penumbra by Johnson & Johnson, have also played a crucial role in shaping the industry landscape. Furthermore, product launches, such as the introduction of Stryker's newest coiling assist device, have showcased innovative solutions for neurovascular procedures. Regulatory changes, including the FDA's updated guidelines for neurovascular devices, have also impacted the industry. These developments highlight the evolving nature of the Neurovascular Coiling Assist Devices industry trends, with a growing emphasis on technological advancements and strategic collaborations.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Neurovascular Coiling Assist Devices market. The market attractiveness is high due to the increasing prevalence of neurovascular diseases and advances in medical technology. The competitive intensity is moderate, with key players focusing on innovation and expansion. The long-term outlook for the Neurovascular Coiling Assist Devices market outlook is positive, driven by rising demand for minimally invasive procedures. The innovation landscape is dynamic, with ongoing research and development of new coiling assist devices. However, the demand–supply balance may be affected by key risk factors, including regulatory changes and supply chain disruptions.

11 items

1. Executive Summary

2. Neurovascular Coiling Assist Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Neurovascular Coiling Assist Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Neurovascular Coiling Assist Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Neurosurgery

6.1.2. Internal Medicine-Neurology

6.1.3. Other

6.2. Global Neurovascular Coiling Assist Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Coil Assist Stents

6.2.2. Coil Assist Balloons

6.3. Global Neurovascular Coiling Assist Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Neurovascular Coiling Assist Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Neurovascular Coiling Assist Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Neurovascular Coiling Assist Devices Market Competition by Key Manufacturers

8.1. Global Neurovascular Coiling Assist Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Neurovascular Coiling Assist Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Stryker Neurovascular

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. MicroVention Inc

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Cerenovus

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Medtronic plc

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Balt Extrusion SAS

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Phenox GmbH

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Acandis GmbH & Co KG

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Neurovascular Coiling Assist Devices Market

Figure 4: Global Neurovascular Coiling Assist Devices Market: Drivers

Figure 5: Global Neurovascular Coiling Assist Devices Market: Challenges

Figure 6: Global Neurovascular Coiling Assist Devices Market: Trends

Figure 7: Global Neurovascular Coiling Assist Devices Market: Opportunity

Figure 8: Global Neurovascular Coiling Assist Devices Market: Restraint

Figure 9: Global Neurovascular Coiling Assist Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Neurovascular Coiling Assist Devices Market Value (USD Million) By Region

Figure 15: Global Neurovascular Coiling Assist Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Neurovascular Coiling Assist Devices Market Value (USD Million) By Region

Figure 23: Global Neurovascular Coiling Assist Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Neurovascular Coiling Assist Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Neurovascular Coiling Assist Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Neurovascular Coiling Assist Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Neurovascular Coiling Assist Devices Market Value (USD Million) By Region

Table 10: Global Neurovascular Coiling Assist Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Neurovascular Coiling Assist Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Neurovascular Coiling Assist Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Neurovascular Coiling Assist Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Stryker Neurovascular Basic Information And Sales Area

Table 31: Stryker Neurovascular. Products Portfolio

Table 32: MicroVention Inc Basic Information And Sales Area

Table 33: MicroVention Inc. Products Portfolio

Table 34: Cerenovus Basic Information And Sales Area

Table 35: Cerenovus. Products Portfolio

Table 36: Medtronic plc Basic Information And Sales Area

Table 37: Medtronic plc. Products Portfolio

Table 38: Balt Extrusion SAS Basic Information And Sales Area

Table 39: Balt Extrusion SAS. Products Portfolio

Table 40: Phenox GmbH Basic Information And Sales Area

Table 41: Phenox GmbH. Products Portfolio

Table 42: Acandis GmbH & Co KG Basic Information And Sales Area

Table 43: Acandis GmbH & Co KG. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global Neurovascular Coiling Assist Devices Market Value (USD Million) By Region

Table 49: Global Neurovascular Coiling Assist Devices Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Neurovascular Coiling Assist Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.40 billion
Revenue forecast in 2033	4.38 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Stryker Neurovascular; MicroVention Inc; Cerenovus; Medtronic plc; Balt Extrusion SAS; Phenox GmbH; Acandis GmbH & Co KG
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options